You are here

CREST: New Biologic Agents in IBD

CREST: New Biologic Agents in IBD | ASCRS

This module discusses the role of biologic agents in IBD, focusing on the new biologic agents, their efficacy and limitations.

Upon completion of this module, participants should be able to:

  • Identify newer biologics used in IBD.
  • Identify mechanisms of action of newer biologics.
  • Review efficacy and future developments.

As a Weekly Curriculum module, it is eligible for 1 AMA PRA Category 1 Credit™.

The ASCRS Online Learning Center provides access to both CREST and CARSEP.  Using your ASCRS website login, you will have access to up-to-date information on colorectal diseases.